SRI
Basic information
Region (hg38): 7:88205115-88226993
Links
Phenotypes
GenCC
Source:
- hypertrophic cardiomyopathy (Refuted Evidence), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SRI gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 14 | 14 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | ||||
non coding | 7 | |||||
Total | 1 | 0 | 14 | 0 | 7 |
Variants in SRI
This is a list of pathogenic ClinVar variants found in the SRI region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-88206370-A-G | Benign (May 15, 2021) | |||
7-88206495-A-G | not specified | Uncertain significance (May 18, 2022) | ||
7-88206698-G-A | Benign (May 15, 2021) | |||
7-88209360-C-T | not specified | Uncertain significance (Jan 15, 2025) | ||
7-88209378-C-G | not specified | Uncertain significance (May 01, 2024) | ||
7-88209410-C-T | not specified | Uncertain significance (Feb 06, 2023) | ||
7-88209429-C-T | not specified | Uncertain significance (Jul 30, 2023) | ||
7-88209986-T-C | not specified | Uncertain significance (Oct 06, 2023) | ||
7-88209998-C-T | not specified | Uncertain significance (Jul 27, 2024) | ||
7-88210033-C-T | not specified | Uncertain significance (May 16, 2024) | ||
7-88210043-C-G | not specified | Uncertain significance (Dec 04, 2024) | ||
7-88210052-T-C | not specified | Uncertain significance (Mar 28, 2024) | ||
7-88210117-C-T | not specified | Uncertain significance (Aug 04, 2024) | ||
7-88210124-T-G | not specified | Uncertain significance (Mar 25, 2024) | ||
7-88210213-A-G | Benign (May 16, 2021) | |||
7-88210375-T-C | Benign (Jun 19, 2021) | |||
7-88210843-G-GA | Benign (May 15, 2021) | |||
7-88210890-T-C | not specified | Uncertain significance (Mar 31, 2024) | ||
7-88210905-G-A | not specified | Uncertain significance (Jun 07, 2024) | ||
7-88210926-C-T | Inborn genetic diseases | Pathogenic (Apr 08, 2014) | ||
7-88210948-T-C | Benign (May 16, 2021) | |||
7-88217190-T-C | not specified | Uncertain significance (Dec 14, 2024) | ||
7-88217196-T-C | Benign (May 06, 2021) | |||
7-88217341-T-G | Benign (May 15, 2021) | |||
7-88219980-C-A | not specified | Uncertain significance (Jan 16, 2025) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SRI | protein_coding | protein_coding | ENST00000265729 | 8 | 21876 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.48e-10 | 0.0945 | 125711 | 0 | 37 | 125748 | 0.000147 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0104 | 110 | 110 | 0.997 | 0.00000568 | 1286 |
Missense in Polyphen | 37 | 36.605 | 1.0108 | 433 | ||
Synonymous | 0.652 | 35 | 40.3 | 0.869 | 0.00000211 | 375 |
Loss of Function | 0.179 | 15 | 15.8 | 0.951 | 9.36e-7 | 155 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000181 | 0.000181 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000435 | 0.000435 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000114 | 0.000114 |
Middle Eastern | 0.000435 | 0.000435 |
South Asian | 0.000327 | 0.000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Calcium-binding protein that modulates excitation- contraction coupling in the heart. Contributes to calcium homeostasis in the heart sarcoplasmic reticulum. Modulates the activity of RYR2 calcium channels. {ECO:0000269|PubMed:17699613}.;
- Pathway
- Stimuli-sensing channels;Ion channel transport;Ion homeostasis;Sodium/Calcium exchangers;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Transport of small molecules;Cardiac conduction;Muscle contraction;EGFR1;Ion transport by P-type ATPases;Hemostasis;Reduction of cytosolic Ca++ levels;Platelet calcium homeostasis;Platelet homeostasis
(Consensus)
Recessive Scores
- pRec
- 0.158
Intolerance Scores
- loftool
- 0.644
- rvis_EVS
- 0.33
- rvis_percentile_EVS
- 73.11
Haploinsufficiency Scores
- pHI
- 0.170
- hipred
- Y
- hipred_score
- 0.622
- ghis
- 0.467
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.551
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sri
- Phenotype
- homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- action potential;calcium ion transport;intracellular sequestering of iron ion;regulation of striated muscle contraction;signal transduction;heart development;muscle organ development;regulation of heart contraction;negative regulation of heart rate;regulation of cell communication by electrical coupling;regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;positive regulation of insulin secretion involved in cellular response to glucose stimulus;cytoplasmic sequestering of transcription factor;positive regulation of release of sequestered calcium ion into cytosol;regulation of calcium ion transport;negative regulation of cardiac muscle contraction;negative regulation of ryanodine-sensitive calcium-release channel activity;regulation of cardiac muscle cell contraction;regulation of relaxation of muscle;regulation of high voltage-gated calcium channel activity;regulation of cell communication by electrical coupling involved in cardiac conduction;negative regulation of transcription regulatory region DNA binding
- Cellular component
- nucleoplasm;cytoplasm;mitochondrion;endoplasmic reticulum membrane;smooth endoplasmic reticulum;cytosol;membrane;sarcoplasmic reticulum;Z disc;T-tubule;sarcoplasmic reticulum membrane;chromaffin granule membrane;axon terminus;dendritic spine neck;extracellular exosome
- Molecular function
- protease binding;signaling receptor binding;calcium channel regulator activity;calcium ion binding;protein binding;ion channel binding;protein heterodimerization activity;repressing transcription factor binding